1. Successful Collaborative Applications Aquaterra Environmental Consulting Inc.

2.  Generally starts with an idea - a shared vision or passion for a particular subject or initiative  Progress includes discussions that identify potential stakeholders, willingness to participate, interest in committing money (cash or in-kind) and/or resources (expertise, site, soil, samples, lab space, client or data access etc.)  Continued dialogue among key partners  Leverage ratio of CRD:other (1:>1)

3. PartnersTitleLeverage Ratio (NSERC:other) Drs. B. Glick & B. Greenberg (UoW), AB Research, ESG International (Stantec) Use of transgenic canola and tobacco plants in the phytoremediation of metal contaminated soil 2:1 Drs. N. Bols & S. Tang (UoW), Stantec, Env. Canada Using ciliates to understand the fate and impact of carbon nanotubes 5:1 Dr. B. Hale (UoG), Glencore Xstrata, Vale, Stantec Bioaccessibility, Bioavailability and Mineralogy of Soil Metal Contaminants for Application to Site Specific Risk Assessment 1:3

4. PartnersTitleLeverage Ratio (Stantec:other) Drs. G. Stephenson (Stantec) B. Greenberg (UoW), Stantec R&D, OCE, RioAlgom (BHP Billiton), TEDCO Application of Different Measures of Bioavailability to Support the Derivation of Risk-based Remedial Benchmarks for Metal- contaminated Sites (Brownfields) 1:3 Drs. G. Stephenson (Stantec), Env. Canada- PERD, Alberta Environment, CAPP Application of Different Measures of Bioavailability to Support the Derivation of Risk-based (Tiers 2 or 3) Remedial Benchmarks for PHC- contaminated Sites 1:5 Drs. G. Stephenson (Stantec) & S. Siciliano, Mitacs, Community for Tomorrow Development and field application of the simulated earthworm gut (SEG) technology for toxicity testing 1:3

5.  Satisfies identified knowledge or data gaps ◦ Meets eligibility criteria ◦ Critical gaps clearly identified ◦ In line with program goals & objectives of stakeholders  Creative and innovative approach ◦ Ensures stakeholder participation & excitement ◦ Alternatively, well planned, well designed ◦ Identified end users of technology  Expertise ◦ Key expertise from academia, industry, and government who can deliver and have a demonstrable success record

6. 1. Is there a scientific or technical uncertainty? 2. Is there a developed hypothesis which can be tested? 3. Does the research follow the scientific method? 4. Are uncertainties addressed or technological advances anticipated? 5. Is there adequate documentation of research & anticipated outcomes identified?

7. “There is nothing that generates money better than the anticipation of success ” “Everyone wants something for nothing or at a fraction of the real cost ” CRD critical ratio - 1:1 Stantec critical ratio – 1:4

8. 1. Conduct research that would otherwise not be possible 2. Competitive advantage 3. Provide solution for a client that satisfies a regulatory requirement 4. Raise the standards in the industry 5. Development of and access to HQP 6. Expanded or other research collaborations through other programs